Patient and Physician Benefit/ Risk Preferences for Treatment of mPC in Hong Kong: a Discrete Choice Experiment

The Chinese University of Hong Kong

Status: Enrolling

Conditions: Prostate Cancer

Study type: Observational

Funder types: Other

Identifiers

NCT05761093

CRE-2022.301

Details and patient eligibility

About

The objective of this study is to examine the preference weightings in term of risk/ benefit attributes of treatment in physician and prostate cancer patients from different stages of disease.

Enrollment: 306 estimated patients

Sex: Male

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• aged 18 years or older,
• diagnosis of metastatic prostate cancer within 5 years,
• able to read and write,
• accepting and signing the informed consent

Exclusion criteria

• if patients are unable to complete the survey by themselves due to physical or psychological reasons,
• deemed ineligible by treating physicians if patients are unable to complete the survey by themselves due to physical or psychological reasons,
• deemed ineligible by treating physicians